DOCSLIB.ORG

Back Pain: an Assessment in Breast Hypertrophy Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Back Pain: an Assessment in Breast Hypertrophy Patients ORIGINAL ARTICLE BACK PAIN: AN ASSESSMENT IN BREAST HYPERTROPHY PATIENTS PAULO MAGALHÃES FERNANDES1, MIGUEL SABINO NETO2, DANIELA FRANCESCATO VEIGA3, LUIS EDUARDODUARDO FELIPE ABLABLA4, CARLOS DELANO ARAÚJO MUNDIM 5, YARAARA JULIANOULIANO6,� LYDIAYDIA MASAKOASAKO FERREIRAERREIRA7 SUMMARY used in order to evaluate the magnitude of back pain and Objective – To evaluate the influence of breast hypertrophy on the limitations arising from these symptoms. Results – The the incidence of back pain and how much they can interfere in mean age of the patients in the study group was 32.2 years patients’ daily activities. Methods – This was a cross-sectional and 32.7 for the control group. The scores in the NRS scale analytic study in patients examined at the Outpatient Ortho- and Roland- Morris Questionnaire were higher in the study pedics and Plastic Surgery Departments at Samuel Libânio group when compared to the control group. Conclusion – The University Hospital in Pouso Alegre, MG. 100 women were results achieved showed that back pain is more severe and examined, 50 presenting breast hypertrophy (study group) determined more extensive limitations in the daily activities and 50 with normal breast size (control group). Breasts were for patients presenting breast hypertrophy. classified according to Sacchini’s criteria. The Numerical Ra- ting Scale (NRS) and the Roland-Morris questionnaire were Keywords: Back pain; Quality of life; Neck pain; Breast. Citation: Fernandes PM, Sabino Neto M, Veiga DF, Abla LEF, Mundim CDA, Juliano Y et al. Back pain: an assessment in breast hypertrophy patients. Acta Ortop Bras. [serial on the Internet]. 2007; 15(4): 227-230. Available from URL: http://www.scielo.br/aob. INTRODUCTION This study intends to assess the influence of breast hyper- Back pain is amongst the most frequent complaints of pa- trophy over painful spinal symptoms and also how much the tients at orthopaedic examination, representing a common usual daily activities of the patients can be compromised as cause of work leaves(1). Spinal pain is sometimes difficult a result of the presence of these symptoms. to evaluate, because many factors can be associated to it, and, sometimes, no correlation is found between clinical METHODS (2) and X-ray findings and symptoms reported . In the period of June 2005 to February 2006, 50 women Breast hypertrophy is described as an abnormal augmenta- with breast hypertrophy referred from Orthopaedics and tion of the breasts, and it has been associated to the emer- Plastic Surgery outpatient services of Hospital das Clíni- gence of various symptoms related to musculoskeletal sys- cas Samuel Libânio, in Pouso Alegre (MG) were assessed. tem, with spinal pain being the most frequent ones (Figure 1). This kind of pain may range from a simple discomfort Other 50 women with normal sized breasts and similar so- to functional disability, with frequent indications to surgical ciodemographic characteristics, which were selected from treatment for reducing breasts volume(3-5). The source of the general population of the region, constituted the con- these symptoms may be postural changes resulting from trol group of the study. No restriction was made in terms gravity center changes, a consequence of breast augmenta- of ethnicity, education level or social layer. Women aged tion, which causes exacerbation of the physiological curves between 18 and 59 years with body mass index (BMI) as 2 of the cervical, thoracic and lumbar spine, additionally to low as 30 Kg/m , who had not been previously submitted to keep cervical and thoracic muscles highly tensioned(6). spinal or breast surgeries, were considered as candidates Several methods have been used to measure painful symp- to the study. Women with BMI below 18.5 Kg/m2, presenting toms as well as restraints resulting from these symptoms. with uncontrolled systemic diseases, who had delivered or The use of standardized questionnaires, of which measure- were breastfeeding in the previous one-year period, with hy- ment properties have already been tested, enables us to pomastia or mammary asymmetry were excluded from the evaluate patients’ profiles through their individual perspec- study. Selected women were enrolled only after signing the tives, being thus possible to assess discomfort and disabil- Free and Informed Consent Term. The study was approved ity determined by a disease or treatment(6,7). by the committee on ethics in research of this institution. Study conducted at the University of Vale do Sapucaí -- Hospital das Clínicas Samuel Libânio - Pouso Alegre - MG. Correspondences to: Rua Cássio Carvalho Coutinho, 26 - Bairro Santa Elisa. Pouso Alegre-MG. CEP: 37550000 - Email:[email protected] 1. Master in Health Sciences by Minter - Interinstitutional Mastery Course UNIFESP/UNIVÁS. Orthopaedic Doctor, Department of Orthopaedics and Traumatology, Hospital das Clínicas Samuel Libânio -University of Vale do Sapucaí- UNIVÁS 2. Associate Professor of the Discipline of Plastic Surgery - UNIFESP 3. Doctor, Plastic Surgery Division, Hospital Clínicas Samuel Libânio - University of Vale do Sapucaí- UNIVÁS 4. Associate Professor, Discipline of Plastic Surgery, UNIFESP 5. Orthopaedic Doctor, Department of Orthopaedics and Traumatology, Hospital das Clínicas Samuel Libânio -University of Vale do Sapucaí- UNIVÁS 6. Chairman, Department of Biostatistics, UNIVÁS 7. Chairman, Discipline of Plastic Surgery, UNIFESP Received in: 10/09/06; Approved in: 11/10/06 226 ACTA ORTOP BRAS 15 (4:222-226, 2007) ACTA ORTOP BRAS 15(4:227-230, 2007) 227 Breasts were rated using the Sacchini’s index. In this classi- ues closer to 24 represent the worst results, that is, more fication, a normal breasts are regarded as those presenting restraints. The questionnaire was applied as an interview, measurements between 9 and 11 cm, hypertrophic breasts performed by only one researcher(11). as those with measurements above 11 cm, and hypomas- For statistical analysis of the results, the Mann-Whitney’s tia, those measurements below 9 cm, in which each breast test was used(12), in order to compare any potentially ex- is individually measured(8) (Figure 2). istent differences between data obtained for control and study groups. The test was applied alone in order to as- sess differences regarding age, NRS and Rolland-Morris questionnaire scores. For comparing BMI values for both groups, the Student’s t test was employed(12). Null hypoth- esis rejection level was determined as 0.05 or 5%. On the line below, please check where you believe your back pain represents today. Zero means absence of pain and ten means excruciating pain. Results Among women with breast hypertrophy (study group), the average age was 32.2 years (± 8.2 years) and the average age for control group was 32.7 years (± 11.1 years). Mean BMI for study group was 25.8Kg/m2 (± 2.59 Kg/m2 ) and for Figure 1 - Woman with breast Figure 2 - Sacchini’s index = average control group, 22.3 Kg/m2 (±2.87 Kg/m2). We noticed no hypertrophy: watch for cervical between X and Y distances. muscles’ and shoulder tension in statistically significant difference between assessed groups order to keep an upright posture. regarding age, while there was a statistically significant dif- ference for BMI (p<0.001), with the hypertrophy group pre- senting a higher BMI than control group (Table 1). The Numeric Scale (NRS) was employed to assess spinal (8) pain severity . The scale presents scores ranging from GROUP N Average Median Standard Minimum Maximum p-value zero to ten, where the patient determines the level in which her pain is according to the scale (Figure 3). The scale was Co�rol 50 32.72 30.00 11.10 20.00 56.00 introduced to patients, which informed the number of the AGE Hyperroph 50 32.20 31.50 8.17 19.00 50.00 0.790 scale that best described the level of their pain severity. Re- To�l 100 32.46 30.50 9.70 19.00 56.00 ports of pain on cervical, thoracic and lumbar spine seg- ments were taken into account. Co�rol 50 59.48 58.50 8.31 44.00 80.00 WEIGHT Hyperroph 50 65.33 66.25 7.11 50.00 80.00 < 0.001* To�l 100 62.41 63.25 8.24 44.00 80.00 Neck: Co�rol 50 1.63 1.63 0.07 1.50 1.77 HEIGHT Hyperroph 50 1.59 1.61 0.07 1.41 1.70 0.003* To�l 100 1.61 1.62 0.07 1.41 1.77 Co�rol 50 22.31 22.00 2.98 18.20 29.00 Dorsal (highest region – near to the shoulders): BMI Hyperroph 50 25.88 26.07 2.59 20.55 30.00 < 0.001* To�l 100 24.09 24.42 3.31 18.20 30.00 Table 1 - Comparison of the groups regarding Age, Weight, Height, and BMI When groups were compared for NRS scores, Roland-Mor- ris Questionnaire and pain scale (NRS), a statistically sig- Lumbar (lowest region of the back): nificant difference was found for all scores. In the group of women with breast hypertrophy, only one patient reported absence of pain in all segments of the spine, while, in con- trol group, 12 women (24%) reported none of these symp- toms. For Roland-Morris Questionnaire, the score zero oc- Figure 3 - Numeric scale for pain severity assessment (NRS) curred in 8% of the women with breast hypertrophy, and in 50% of the women in control group. The Roland-Morris Questionnaire(9,10) enables to evaluate The results of NRS pain assessment and the results of physical restraints resulting from reported pain on lumbar the analysis of Roland-Morris questionnaire are shown on spine and has been used to evaluate restraints resulting Table 2. from other spinal segments, as well. The questionnaire is composed of 24 yes/no questions, where each positive an- DISCUSSION swer corresponds to a score.
Load more

Recommended publications
  • Spectrum of Breast Disorders in a Pediatric Surgery Clinic: Retrospective Study
    Article ID: WMC003775 ISSN 2046-1690 Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study Corresponding Author: Dr. Atilla Senayli, Assistant Prof., Pediatric Surgery, Yildirim Beyazit University - Turkey Submitting Author: Dr. Atilla Senayli, Assistant Prof., Pediatric Surgery, Yildirim Beyazit University - Turkey Article ID: WMC003775 Article Type: Original Articles Submitted on:26-Oct-2012, 05:59:39 AM GMT Published on: 26-Oct-2012, 06:25:34 PM GMT Article URL: http://www.webmedcentral.com/article_view/3775 Subject Categories:PAEDIATRIC SURGERY Keywords:Breast; Disorders; Children How to cite the article:Senayli A, Karaveliolu A , Koseoglu B , Akln M , Ozguner I . Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study . WebmedCentral PAEDIATRIC SURGERY 2012;3(10):WMC003775 Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Source(s) of Funding: None Competing Interests: None WebmedCentral > Original Articles Page 1 of 7 WMC003775 Downloaded from http://www.webmedcentral.com on 26-Oct-2012, 06:25:34 PM Spectrum of Breast Disorders in A Pediatric Surgery Clinic: Retrospective Study Author(s): Senayli A, Karaveliolu A , Koseoglu B , Akln M , Ozguner I Abstract Paediatricians must pay attention to breast disorders that may be seen at any paediatric age group. (1). Objective: There are a limited and inadequate data Although most of the diseases are benign as a fact, for breast diseases in children. This may be because the possibility of malignancy can never be ignored of low importance expectations of practitioners' for (1-3).
    [Show full text]
  • Journal of Clinical Review & Case Reports
    ISSN: 2573-9565 Case Report Journal of Clinical Review & Case Reports Pseudo Angiomatous Stromal Hyperplasia of the Breast: A Case of A 19-Year-Old Asian Girl Yuzhu Zhang1, Weihong Zhang2# , Yijia Bao1, Yongxi Yuan1,3* 1Department of Mammary gland, Longhua Hospital Affiliated to Shanghai University of TCM, Shanghai, China *Corresponding author 2Department of Mammary gland, Baoshan branch of Shuguang Yongxi Yuan, Department of Mammary gland, Longhua Hospital Hospital Affiliated to Shanghai University of TCM, Shanghai,201900, Affiliated to Shanghai University of TCM & Huashan Hospital, China. Shanghai Medical College, Fudan University, Shanghai, China. Tel: +8602164383725; Email: [email protected] 3Department of Mammary gland, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China Submitted: 11 Oct 2017; Accepted: 20 Oct 2017; Published: 04 Nov 2017 #co-first author Abstract Pseudoangiomatous stromal hyperplasia (PASH), a benign disease with extremely low incidence, is manifested as giant breasts, frequent relapse after surgery, or endocrine disorder. Cases with unilateral breast and undetailed endocrine condition have been reported in African and American. In this case, a 19-year-old Asian girl suffered from bilateral breast PASH after the human placenta and progesterone treatment for 3-month delayed menstruation. Her breasts enlarged remarkably 1 month after the treatment, with extensive inflammatory swell in bilateral mammary glands and subcutaneous edema in retromammary space. The patient received the bilateral quadrantectomy plus breast reduction and suspension surgery to terminate the progressive hyperplasia of breast. During the whole treatment period, the patient was given tamoxifen treatment for 4 months, and endocrine levels were intensively recorded. The follow-up after 4 months showed recovered breast with normal shape and size, and there was no distending pain, a tendency toward breast hyperplasia, or menstrual disorder.
    [Show full text]
  • Juvenile Breast Hypertrophy
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Via Medica Journals ONLINE FIRST This is a provisional PDF only. Copyedited and fully formatted version will be made available soon. ISSN: 0423-104X e-ISSN: 2299-8306 Juvenile breast hypertrophy Authors: Benedita Bianchi de Aguiar, Rita Santos Silva, Carla Costa, Cintia Castro-Correia, Manuel Fontoura DOI: 10.5603/EP.a2019.0063 Article type: Clinical Vignette Submitted: 2019-12-07 Accepted: 2019-12-16 Published online: 2020-01-07 This article has been peer reviewed and published immediately upon acceptance. It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited. Articles in "Endokrynologia Polska" are listed in PubMed. The final version may contain major or minor changes. Powered by TCPDF (www.tcpdf.org) Juvenile breast hypertrophy Benedita Bianchi de Aguiar1, Rita Santos Silva2, Carla Costa2, Cintia Castro-Correia2, Manuel Fontoura2 1Paediatrics Department, Centro Hospital Entre Douro e Vouga, Portugal 2Paediatrics Endocrinology, Centro Hospitalar Universitário de São João, Portugal Correspondence to: Benedita Sousa Amaral Bianchi de Aguiar, Rua Marta Mesquita da Câmara 175 Apt 62 4150-485 Porto, Portugal, tel: (+351) 913 166 913; e-mail: [email protected] Case description Juvenile breast hypertrophy (JBH), also called virginal hypertrophy or macromastia, is a rare benign condition, in which one or both breasts undergo a massive increase in size duringin puberty, usually around menarche. We present a clinical case of JBH and discuss the available therapeutic options. An 11-year- old female patient was referred to our paediatric endocrinologist consultant due to breast hypertrophy.
    [Show full text]
  • W O 2019/232146 Al 05 December 2019 (05.12.2019) W IPO I PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property (1) Organization11111111111111111111111I1111111111111i1111liiiii International Bureau (10) International Publication Number (43) International Publication Date W O 2019/232146 Al 05 December 2019 (05.12.2019) W IPO I PCT (51) International Patent Classification: JIANG, Zaoli; 20 Cedar Rock Road, Woodbridge, Con A61K31/19(2006.01) A61K45/00(2006.01) necticut06525(US). A61K38/12 (2006.01) A61K 45/08 (2006.01) (74) Agent: DOYLE, Kathryn et al.; Saul Ewing Arnstein & (21) International Application Number: Lehr LLP, 1500 Market Street, 38th Floor, Philadelphia, PCT/US2019/034548 Pennsylvania 19102 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 30 May 2019 (30.05.2019) kind ofnational protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (25)FilingLanguage: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (26) Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (30)PriorityData: HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (30)/Priority : 01 June 2018 (01.06.2018) us KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (71) Applicant: YALE UNIVERSITY [US/US]; Two Whitney OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, Avenue, New Haven, Connecticut 06510 (US). SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, ZA, ZM, ZW.
    [Show full text]
  • Chronic Cystic Mastitis with Special Relation to Carcinoma
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1937 Chronic cystic mastitis with special relation to carcinoma John D. Hamer University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Hamer, John D., "Chronic cystic mastitis with special relation to carcinoma" (1937). MD Theses. 512. https://digitalcommons.unmc.edu/mdtheses/512 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. CHRONIC CYSTIC IvIASTITIS va th Special Relation to Carcinoma Senior Tbesis Presented to the University of Nebraska College of Medicine by .John D. Hamer INTRODUCTION The purpose of this paper is to better acquaint the student wi th the ever changing views of investigators regarding the relationship of Chronic cystic mastitis to carcinoma of the breast. The Buthor has borne in mind that until recent years very little work of an experimental nature has been done in this field. Consequently the material from which this paper is made up has been ex­ tracted from current articles upon this subject. He has set down clinical find­ ings, experimental results, and theories of the different workers with an open mind. He has tried not to form an opin­ ion but would rather let the reader form come to his own conclusions, 480871 CHRONIC CYSTIC 1MSTITIS Definition - Chronic Cystic Mastitis is a misnomer.
    [Show full text]
  • Pediatric and Adolescent Breast Masses
    Pediatric Imaging • Review Kaneda et al. Pediatric and Adolescent Breast Masses Pediatric Imaging Review Pediatric and Adolescent Breast Masses: A Review of Pathophysiology, Imaging, Diagnosis, and Treatment Heather J. Kaneda1 OBJECTIVE. Pediatric breast masses are relatively rare and most are benign. Most are Julie Mack either secondary to normal developmental changes or neoplastic processes with a relatively Claudia J. Kasales benign behavior. To fully understand pediatric breast disease, it is important to have a firm Susann Schetter comprehension of normal development and of the various tumors that can arise. Physical ex- amination and targeted history (including family history) are key to appropriate patient man- Kaneda HJ, Mack J, Kasales CJ, Schetter S agement. When indicated, ultrasound is the imaging modality of choice. The purpose of this article is to review the benign breast conditions that arise as part of the spectrum of normal breast development, as well as the usually benign but neoplastic process that may develop within an otherwise normal breast. Rare primary carcinomas and metastatic lesions to the pediatric breast will also be addressed. The associated imaging findings will be reviewed, as well as treatment strategies for clinical management of the pediatric patient with signs or symptoms of breast disease. CONCLUSION. The majority of breast abnormalities in the pediatric patient are be- nign, but malignancies do occur. Careful attention to patient presentation, history, and clini- cal findings will help guide appropriate imaging and therapeutic decisions. hough breast masses are uncom- mary breast cancer is extremely low in the pe- mon in the pediatric population, diatric population, reducing the utility of mam- the detection of an abnormality is mography as a diagnostic problem-solving tool T often alarming to caregivers and [1].
    [Show full text]
  • Laktation & Stillen
    LactationLaktation & Breastfeeding & Stillen ZeitschriftMagazine der of theEuropäischen European LactationLaktationsberaterinnen Consultants Alliance Allianz • www.elacta.eu • ISSNISSN 1614-807x1614-807x COVER STORY PRACTICAL KNOW HOW PRACTICAL KNOW HOW Breastfeeding After Cosmetic Infant Hand Movements During Do Mothers Really Have The Choice th Breast Surgery – page 15 Breast Seeking – page 6 To Breastfeed? – page 10 3 • 2017 30 Volume Foto: Field exchange 48 2 EDITORIAL EDITORIAL Dear members, dear colleagues, dear readers, IMPRINT summer has gone, it has started raining, the wind is blow- Company Information: ELACTA European Lactation ing and leaves are falling from trees. In this ELACTA mag- Consultants Alliance azine you will find some nice issues to read about, even by www.elacta.eu authors from overseas. About situations that will come up Email: [email protected] ZVR-Nr.: 708420941 unexpectedly and are sometimes unwanted. Our profession is really important, also after hospitalization. Convince your ELACTA president: Karin Tiktak, IBCLC colleagues and other health care providers about the impor- [email protected] tant role you play as an IBCLC. Editorial and project Actually the ELACTA board is writing this editorial from coordination: Opatija in Croatia. It is a beautiful place where one of our Eva Bogensperger-Hezel, IBCLC board members lives and does her job as an IBCLC in her pri- Email: [email protected] vate practice. We have board meetings on Friday and Saturday Team: from 9 am to 5 pm. During this enjoyable time together, we Andrea Hemmelmayr, IBCLC Elke Cramer, Ärztin, IBCLC bridge the differences we experience in lactational care. Be- Kathrin Meier, IBCLC ing the president of this important association makes me feel Bärbel Waldura, IBCLC grateful and responible.
    [Show full text]
  • Gynecomastia Info
    Page 1 of 4 GYNECOMASTIA TYPES AND TREATMENTS by JAMES ROMANO, MD Gynecomastia is usually strictly defined as the visible or palpable development of breast tissue in men. The term comes from the Greek words gyne meaning "woman" and mastos meaning "breast." In practical terms, this means abnormally large breasts on men. This is often related to the occurrence of excess fat or, less frequently, overdeveloped muscles. The condition is relatively common in adolescent boys, and 90% of the time symptoms disappear in a matter of months, or, as adolescence wanes, a few years later. But the remaining 10% are burdened with a social handicap that causes a deep and complex shame, and often puts a man’s relationship with his body into an altered state. Drugs, medications, hormonal imbalance, genetic conditions, and exogenous hormones can all cause gynecomastia. During puberty it is normal for most boys to develop some proliferation of breast tissue. This is often make known by the onset of pain in the nipples or sub-areolar region. Ordinarily this condition is self-limited and subsides within 6 to 18 months. When this gynecomastia persists, it is often embarrassing and psychologically debilitating. Removal of the excess breast parenchyma is the only effective treatment. This condition can be accentuated if the patient is overweight. Marijuana usage is commonly linked to gynecomastia. Men who are taking estrogens or testosterone inhibitors because of prostate cancer or patients with liver disease who have a hormonal imbalance are also susceptible to this condition. Gynecomastia can develop as a result of taking anabolic steroids to enhance athletic performance or bodybuilding.
    [Show full text]
  • Neonatal Breast Hypertrophy
    & The ics ra tr pe a u i t i d c e s P Pediatrics & Therapeutics Donaire et al., Pediatr Ther 2016, 6:3 ISSN: 2161-0665 DOI: 10.4172/2161-0665.1000297 Case Report Open Access Neonatal Breast Hypertrophy: Revisited Alvaro Donaire, Juan Guillen and Benamanahalli Rajegowda* Department of Pediatrics, Lincoln Medical and Mental Health Center, USA *Corresponding author: Benamanahalli Rajegowda, Department of Pediatrics, Division of Neonatology, Lincoln Medical and Mental Health Center, 234 East 149th Street, Bronx, New York, 10451, USA, Tel: 718-579-5360; Fax: 718-579-4958; E-mail: [email protected] Received date: Jun 28, 2016, Accepted date: Jul 14, 2016, Published date: Jul 18, 2016 Copyright: © 2016 Donaire A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Introduction Neonatal breast enlargement is a benign condition that may be seen during the first days of life in the neonatal period and it has been reported to occur in 65-90% of infants. Within few months after birth it usually involutes, and later regrows during puberty due to hormonal stimulation. Breast enlargement is uncommon, when it occurs is a benign physical finding [1]. Neonatal galactorrhea, commonly referred to as witch’s milk, is a cloudy discharge from the breasts that occurs when estrogen and progesterone levels decrease after delivery, enabling the secretion of prolactin and oxytocin from the neonate’s pituitary [2]. The “witch’s milk” resembles the maternal milk composition, the milk comes only when the breast are expressed.
    [Show full text]
  • Macromastia - Reduction Mammoplasty
    Macromastia - Reduction Mammoplasty Reduction mammoplasty or breast reduction surgery reduces the volume and weight of the breasts by removing excess fat, glandular tissue and skin. The procedure is performed in ​ order to alleviate or correct medical problems caused by excessive breast tissue. Women ​ presenting with various forms of breast hypertrophy accompanied by persistent clinical signs and symptoms that adversely affect health are the principal candidates for breast reduction surgery. Note: Reduction mammoplasty performed as part of gender affirming surgeries are NOT ​ covered under this clinical criteria. Reduction mammoplasty will be considered for coverage when ALL of the criteria below are ​ met, confirmed with supporting medical documentation. I. Criteria for Initial Approval ● Documentation of a functional impairment (defined as adverse effect on activities of daily living) related to at least two of the following: ​ ​ ○ Chronic pain ■ Chronic headaches. ■ Chronic upper back, neck, breast or shoulder pain. ○ Skin changes ■ Signs and symptoms of intertriginous maceration and/or infection of the inframammary skin (e.g., hyperpigmentation, bleeding, chronic moisture, and evidence of skin breakdown refractory to dermatologic measures). ■ Shoulder grooving from bra straps. ○ Arthritic changes ■ Signs and symptoms of nerve compression that are unresponsive to medical management (e.g., ulnar paresthesias) and evidenced ​ by nerve conduction studies. ■ History of significant arthritic changes in the cervical or upper thoracic spine. ■ Thoracic outlet syndrome. ■ Acquired kyphosis that is attributed to macromastia. ○ Dysmorphic Syndrome ■ Depression/significant anxiety related to macromastia. 1 ● Medical opinion that these functional impairments are attributable to macromastia. ○ Documented exclusion of alternative etiologies (e.g., such as arthritis, multiple sclerosis, cervical spine disease, etc.) have been adequately ruled-out by means of diagnostics, as applicable.
    [Show full text]
  • Breast Diseases in Children: the Spectrum of Radiologic Findings in a Cohort Study
    Diagn Interv Radiol 2017; 23:407–413 BREAST IMAGING © Turkish Society of Radiology 2017 ORIGINAL ARTICLE Breast diseases in children: the spectrum of radiologic findings in a cohort study Emel Durmaz PURPOSE Murat Alp Öztek We aimed to investigate the spectrum of radiologic findings and referral reasons for breast dis- Hatice Arıöz Habibi eases in children considering age-appropriate presentation. Uğur Kesimal METHODS Hakkı Timur Sindel Our retrospective cohort study included 348 consecutive pediatric patients aged <19 years (me- dian, 13 years) referred to radiology with a clinical presentation between 2005 and 2016. Radio- logic findings were reviewed in four age ranges (0–2 years, 2–8 years, 8–15 years, >15 years). RESULTS Of 348 patients, 257 had a referral reason. The most frequent referral reason was a palpable mass (35%). Developmental abnormalities accounted for 48% of all radiologic findings in 348 patients. We did not detect any breast malignancy. According to age groups, the most common radiologic findings were neonatal hypertrophy (0–2 years), early breast development (2–8 years), develop- mental abnormalities by a majority of gynecomastia (8–15 years), and normal findings or devel- opmental abnormalities (>15 years). Interestingly, the frequency of gynecomastia was only 4% in neonatal period or early childhood. Fibroadenomas and fibroadenoma-like solid masses were seen after 8 years and constituted the majority of solid masses (65%). Cysts were seen at a rate of 7% and majority of them were of simple type, which tends to resolve in time. CONCLUSION In our study, the most common referral reason to radiology was a palpable breast mass.
    [Show full text]
  • Neonatal Mastauxe (Breast Enlargement of the Newborn)
    Journal of Neonatal Surgery 2013;2(3):31 ATHENA’S PAGES Neonatal Mastauxe (Breast Enlargement of the Newborn) V. Raveenthiran Department of Pediatric Surgery, Sri Ramasamy Memorial (SRM) Medical College, SRM University, Chennai 603203, India (Athena stands for abbreviation of Abstracting and Thoughtful Evaluation of Neonatal Articles; but it is also personified by the contributor. Like Athena of Greek mythology, she distills wisdom from published literature) Maternal estrogen is known to cause varying lactalbumin [6]. Inadequate let-out of milk, ei- degree of breast enlargement in approximately ther due to improper canalization of lactiferous 70% of newborn. [1] Usually the diameter of ducts or due to lack of oxytocin stimulus in the breast bud measures 1 to 2 cm in the first few newborn, may lead to stagnation of milk weeks of life [2]. But Athena has seen some of (galactocele). Superadded infection may result these breasts of alarming size (Figure 1). in complications such as mastitis and breast abscess [7]. Athena intends to update the re- cent developments on this oddity of the Nature. An extensive review of literature has left Athena much disappointed for many reasons. First of all, there is no proper terminology to describe uncomplicated, physiological enlargement of breasts in the newborn. Research papers sel- dom distinguish various forms of breast swell- ings in newborn such as physiological enlarge- ment, exaggerated development, bulging galactocele, inflammatory swelling and breast abscess. Terms such as ‘mastitis’ [8,9,10], ‘galactorrhea’ [4,11], ‘gynecomastia’ [11,12], ‘galactocele’ [12,13], ‘breast hypertrophy’[14] and ‘breast enlargement’[1] have been used in- terchangeably to denote any of the aforemen- Figure 1: Giant Mastauxe of newborn.
    [Show full text]